Contact
 

Webinar Announcement: The anti-HIV Activity of Natural Killer Cells

The Canadian HIV Vaccine Initiative (CHVI) Research and Development Alliance Coordinating Office (ACO) invite you to join their webinar on “The anti-HIV activity of Natural Killer cells: Their role in protection from and control of HIV infectionwith Dr. Nicole Bernard.  This webinar will provide participants with a greater understanding of the role of NK cells, their receptors and ligands in the protection from and control of HIV infection; and will include basic concepts about NK cells, studies that NK cell receptors and ligands influence protection from HIV infection and how a protective KIR/HLA genotype influences NK cell functions controlling HIV replication.

When:  Friday October 17th, 2014

Time: 1:00-2:00 pm EDT (12:00 – 1:00 pm CDT, 11:00 am – 12:00 pm MDT and 10:00 am – 11:00 pm PDT)

Presenter:

Dr. Nicole Bernard, Research Institute of the McGill University Health Centre

Learning Objectives:
By the end of the webinar you will be able to:  

  1. Understand some basic concepts about Natural Killer (NK) cells, their receptor and their ligands.
  2. Review the epidemiological studies showing that genes encoding NK cell receptors called KIR and their HLA ligands influence protection from HIV infection and HIV control in infected persons.
  3. Learn how a protective KIR/HLA genotype influences NK cell functions that can control HIV replication.

Contact aco-projects@icid.com to register for the webinar. 

Global HIV Vaccine Enterprise, 64 Beaver Street, # 352, New York, NY 10004 | +1 212-461-3692 or toll free at +1-866-966-4483
All Content ©2005 - 2013 Global HIV Vaccine Enterprise   |   Terms of Use   |   Privacy Policy   |   Log In / My Account